• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Study suggests over half of women with gestational diabetes in the UK are going undiagnosed

Dec 17, 2024
A group of pregnant women

Research investigating testing methods for gestational diabetes suggests that over half of pregnant women with the condition are not being diagnosed with the current NHS blood test process, leading to unnecessary complications for mother and baby.

The study, carried out by Professor Claire Meek of the University of Leicester, and colleagues at the University of Cambridge with funding from the National Institute of Health and Care Research (NIHR) found that processing the blood sugar test of mothers at risk of gestational diabetes more quickly could lead to more accurate diagnosis of this serious condition.

These findings were published in the journal Diabetic Medicine on 17 December 2024.

Professor of Chemical Pathology and Diabetes in Pregnancy, Claire Meek said: “Gestational diabetes, which affects women in pregnancy, is very common in the UK and causes complications at the time of birth, affecting both mother and child.

Professor Claire Meek
Professor Claire Meek

“Fortunately, most complications can be prevented by accurate diagnosis and access to treatment. However, if the diagnosis is not accurate, then affected mothers cannot access the treatment they need.”

Gestational diabetes is diagnosed using an oral glucose tolerance test (OGTT) around 24 to 28 weeks of pregnancy.

This test involves taking the mother’s blood before they consume a sugary drink. A further sample is taken and tested two hours later. However, red blood cells in the sample continue to use up glucose after the blood is taken, so glucose concentrations fall over time in the sample tube, leading to an inaccurate result.

Processing the blood quickly means that the glucose levels in the sample are most similar to the glucose levels in the patient’s blood.

“We wanted to assess if processing the samples more quickly improved the accuracy of the OGTT test.” continued Professor Meek.  “We compared standard NHS sample processing procedures to an enhanced processing plan, where the blood was processed more quickly.”

Using standard NHS sample processing procedures, 9% of women in the study were diagnosed with the condition. The researchers found that when blood was processed more quickly, 22% of women in the study were found to have gestational diabetes.

This means that 13% of women were missed with the standard test.  More than half the women they found to have gestational diabetes in the study would have done undiagnosed.

Scaling this up, this could affect around 28,000-30,000 pregnant women every year in the UK.

Danielle Jones, the PhD student who coordinated the research project added: “Faster blood processing identified additional women with raised blood sugar levels that were missed by the standard test. Thirty seven percent of these women went on to have large babies – a complication which could have been prevented if undiagnosed women had access to treatment.”

The data from this study suggests that improving NHS sample processing is vital to improve gestational diabetes diagnosis. Access to treatment may also help prevent babies from growing too large. Processing blood more quickly (within 2 to 4 hours) is achievable in most NHS settings and offers new opportunities to improve the health of mothers and babies.

For the full paper please visit: Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes – Jones – Diabetic Medicine – Wiley Online Library


For more on the work of our Lifestyle theme, please click here to visit their pages.

Category: Press ReleasesTag: diabetes, gestational diabetes, lifestyle, News, pregnancy, Press Release

Sidebar

Recent News

People with long Covid have drastically different microbiome in their lungs and mouth

New plan to tackle unreliable research antibodies could save millions and improve medical research

Study shows low energy diet combined with structured exercise reverses early onset type 2 diabetes in half of participants

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}